| Robert R Dai, MD | |
|
115 Lincoln St, Framingham, MA 01702-6358 | |
| (508) 383-1730 | |
| Not Available |
| Full Name | Robert R Dai |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 41 Years |
| Location | 115 Lincoln St, Framingham, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851326870 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 208811 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Metrowest Medical Center | Framingham, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capa Anesthesia Llc | 1850786393 | 48 |
| Metrowest Anesthesia Associates Llc | 8224397351 | 19 |
News Archive
The U.S. Pharmacopeia (USP) is pleased to announce 11 new proposed monographs for dietary supplements for public notice and comment.
Yesterday's court decision triggered a wave of analysis, speculation, posturing and predictions about what health reform's future will hold.
Insmed Incorporated today reported results from the Company's phase 2 clinical trial of ARIKAYCETM, or liposomal amikacin for inhalation, for the treatment of patients with treatment resistant nontuberculous mycobacterial (NTM) lung infections.
Before epilepsy surgery, doctors may consider using brain imaging to locate language and memory functions in the brain instead of the more invasive procedure that is commonly used, according to a guideline published by the American Academy of Neurology in the January 11, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
As a part of the COMMUNITY (COVID-19 Immunity) study, researchers from Sweden reveal long-lasting IgG neutralizing antibody response against spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the vast majority of convalescent individuals – even after asymptomatic or mild infection. Their results are currently available on medRxiv* preprint server.
› Verified 9 days ago
| Entity Name | Metrowest Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104339902 PECOS PAC ID: 8224397351 Enrollment ID: O20180118001957 |
News Archive
The U.S. Pharmacopeia (USP) is pleased to announce 11 new proposed monographs for dietary supplements for public notice and comment.
Yesterday's court decision triggered a wave of analysis, speculation, posturing and predictions about what health reform's future will hold.
Insmed Incorporated today reported results from the Company's phase 2 clinical trial of ARIKAYCETM, or liposomal amikacin for inhalation, for the treatment of patients with treatment resistant nontuberculous mycobacterial (NTM) lung infections.
Before epilepsy surgery, doctors may consider using brain imaging to locate language and memory functions in the brain instead of the more invasive procedure that is commonly used, according to a guideline published by the American Academy of Neurology in the January 11, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
As a part of the COMMUNITY (COVID-19 Immunity) study, researchers from Sweden reveal long-lasting IgG neutralizing antibody response against spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the vast majority of convalescent individuals – even after asymptomatic or mild infection. Their results are currently available on medRxiv* preprint server.
› Verified 9 days ago
| Entity Name | Capa Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629723002 PECOS PAC ID: 1850786393 Enrollment ID: O20220318000777 |
News Archive
The U.S. Pharmacopeia (USP) is pleased to announce 11 new proposed monographs for dietary supplements for public notice and comment.
Yesterday's court decision triggered a wave of analysis, speculation, posturing and predictions about what health reform's future will hold.
Insmed Incorporated today reported results from the Company's phase 2 clinical trial of ARIKAYCETM, or liposomal amikacin for inhalation, for the treatment of patients with treatment resistant nontuberculous mycobacterial (NTM) lung infections.
Before epilepsy surgery, doctors may consider using brain imaging to locate language and memory functions in the brain instead of the more invasive procedure that is commonly used, according to a guideline published by the American Academy of Neurology in the January 11, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
As a part of the COMMUNITY (COVID-19 Immunity) study, researchers from Sweden reveal long-lasting IgG neutralizing antibody response against spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the vast majority of convalescent individuals – even after asymptomatic or mild infection. Their results are currently available on medRxiv* preprint server.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert R Dai, MD 15 Mellen Ln, Wayland, MA 01778-2006 Ph: (781) 979-3970 | Robert R Dai, MD 115 Lincoln St, Framingham, MA 01702-6358 Ph: (508) 383-1730 |
News Archive
The U.S. Pharmacopeia (USP) is pleased to announce 11 new proposed monographs for dietary supplements for public notice and comment.
Yesterday's court decision triggered a wave of analysis, speculation, posturing and predictions about what health reform's future will hold.
Insmed Incorporated today reported results from the Company's phase 2 clinical trial of ARIKAYCETM, or liposomal amikacin for inhalation, for the treatment of patients with treatment resistant nontuberculous mycobacterial (NTM) lung infections.
Before epilepsy surgery, doctors may consider using brain imaging to locate language and memory functions in the brain instead of the more invasive procedure that is commonly used, according to a guideline published by the American Academy of Neurology in the January 11, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
As a part of the COMMUNITY (COVID-19 Immunity) study, researchers from Sweden reveal long-lasting IgG neutralizing antibody response against spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the vast majority of convalescent individuals – even after asymptomatic or mild infection. Their results are currently available on medRxiv* preprint server.
› Verified 9 days ago
Josef Pleticha, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1572 | |
Dr. Janet D Pearl, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 600 Worcester Rd Ste 301, Framingham, MA 01702 Phone: 508-665-4344 Fax: 508-665-4355 | |
Matthew Aranow, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1000 | |
Dr. Peter M. Ting, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-875-1600 Fax: 508-875-1297 | |
Dr. Barbara L Hartwell, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-875-1600 Fax: 508-875-1297 | |
Dr. Regina Torelli, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-875-1600 Fax: 508-875-1297 | |
Dr. Arpa P Mahasaen, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-875-1600 Fax: 508-875-1297 |